June 4, 2021 (LifeSiteNews) – Yet another study has been published supporting the conclusion that people who contract COVID-19 and recover remain immune to reinfection for a “substantial” period of time, potentially dashing health bureaucrats’ hopes of making COVID vaccinations and booster shots a long-term feature of American life.
The study, published in The Lancet’s journal EClinicalMedicine, examined data from antibodies in 39,086 individuals who tested positive for COVID-19 from March 2020 and January 2021, taking advantage of Laboratory Corporation of America Holdings (Labcorp), “one of the United States’ largest diagnostic laboratories, which has access to some of the most substantial longitudinal data on COVID-19.” It found an “encouraging timeline for the development and sustainability of antibodies up to ten months from natural infection.”
The researchers caution that their findings were limited by the lack of “advanced demographic (race, ethnicity, etc.) and diagnostic information (disease severity)” in the data they were using, and their reliance on multiple types of antibody tests limiting the “specificity of how much antibodies remain in the system.” Therefore, “true SARS-CoV-2 antibody kinetics are still unknown, and require more time from sample collection and monitoring.”
Still, they say their findings show a “sustained positivity rate of
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors